Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Comito
Observed names:
Comito, Francesca,
F. Comito,
FRANCESCA COMITO,
Francesca COMITO
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
Royal Marsden NHS Foundation Trust,
Università Campus Bio-Medico,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Royal Marsden Hospital,
Istituto delle Scienze Neurologiche di Bologna,
University of Bologna
show all 6
ORCID:
0000-0002-8591-0788
Observed ORCID:
0000-0002-8591-0788
OpenAlex ID:
A5047236287
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
2015
·
Bruno Vincenzi
, Massimo Di Maio
, et al.
·
PLoS ONE
·
163
PDF
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis
2022
·
Giuseppe Viscardi
, Antonino C. Tralongo
, et al.
·
European Journal of Cancer
·
162
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023
·
Simone Rossi
, Francesco Gelsomino
, et al.
·
Journal of Neurology
·
70
PDF
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
2022
·
Giorgio Durante
, Elisabetta Broseghini
, et al.
·
Expert Review of Molecular Diagnostics
·
48
Influenza Vaccine Indication During Therapy with Immune Checkpoint Inhibitors: A Transversal Challenge. The Invidia Study
2018
·
Melissa Bersanelli
, Diana Giannarelli
, et al.
·
Immunotherapy
·
48
PDF
Adjuvant therapy in renal cell carcinoma
2017
·
Francesco Massari
, Vincenzo Di Nunno
, et al.
·
Cancer Treatment Reviews
·
48
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
2022
·
Francesca Comito
, Rachele Pagani
, et al.
·
Cancers
·
35
PDF
Non-coding RNA dysregulation in skin cancers
2021
·
Giorgio Durante
, Francesca Comito
, et al.
·
Essays in Biochemistry
·
32
Lung Nodule and Functional Changes in Smokers After Smoking Cessation Short-Term Treatment
2014
·
Eliana Maci
, Francesca Comito
, et al.
·
Cancer Investigation
·
30
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study
2023
·
Matthew R. Orton
, Evan Hann
, et al.
·
Cancer Imaging
·
22
PDF
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis
2020
·
Francesca Comito
, Isla Leslie
, et al.
·
Journal of Immunotherapy
·
19
Neoadjuvant treatment of basosquamous carcinomas with Sonidegib: An innovative approach
2023
·
Emi Dika
, Barbara Melotti
, et al.
·
Experimental Dermatology
·
18
Circulating tumor cells in genitourinary tumors
2017
·
Francesco Massari
, Vincenzo Di Nunno
, et al.
·
Therapeutic Advances in Urology
·
17
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
2020
·
Giovanni Vitale
, Giuseppe Lamberti
, et al.
·
Expert Opinion on Biological Therapy
·
14
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis
2018
·
Elisa Grassi
, Sandra Durante
, et al.
·
International Journal of Oncology
·
14
PDF
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY
2023
·
Emanuel Raschi
, Francesca Comito
, et al.
·
Immunotherapy
·
13
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel
2024
·
Thais Maloberti
, Antonio De Leo
, et al.
·
Diagnostics
·
12
PDF
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab
2021
·
Francesca Comito
, Maria C. Nigro
, et al.
·
European Journal of Cancer
·
12
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience
2022
·
Francesca Comito
, Marta Aprile
, et al.
·
Melanoma Research
·
10
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institution
2020
·
C. L. Edwards
, F. Comito
, et al.
·
Clinical and Experimental Dermatology
·
9
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma
2018
·
Francesca Comito
, Valentina Ambrosini
, et al.
·
Anti-Cancer Drugs
·
8
Defining high-risk patients: beyond the 8the AJCC melanoma staging system
2024
·
Elisabetta Broseghini
, Giulia Veronesi
, et al.
·
Archives of Dermatological Research
·
7
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2022
·
Simone Rossi
, Ilaria Cani
, et al.
·
Journal of Clinical Oncology
·
7
PDF
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report
2018
·
Francesca Comito
, Elisa Grassi
, et al.
·
BJR|case reports
·
7
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
2024
·
Andrea De Giglio
, Alessandro Leonetti
, et al.
·
Cancer Immunology Immunotherapy
·
6
PDF
Show more works
View as search
Works count:
51
Citation count:
862
H-index:
14
I10-index:
19
Year
Topic
Type